Walleye Trading’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-520
Closed -$12.6K 4375
2025
Q3
$12.6K Sell
520
-2,000
-79% -$33.3K ﹤0.01% 4183
2025
Q2
$41.5K Buy
2,520
+1,870
+288% +$32.3K ﹤0.01% 3854
2025
Q1
$11.8K Sell
650
-320
-33% -$9.14K ﹤0.01% 3833
2024
Q4
$36K Sell
970
-2,400
-71% -$91.8K ﹤0.01% 3858
2024
Q3
$108K Sell
3,370
-420
-11% -$23.3K ﹤0.01% 3288
2024
Q2
$311K Buy
3,790
+2,250
+146% +$243K ﹤0.01% 2818
2024
Q1
$223K Buy
1,540
+1,530
+15,300% +$129K ﹤0.01% 3366
2023
Q4
$921 Sell
10
-50
-83% -$5.08K ﹤0.01% 4922
2023
Q3
$9.9K Buy
+60
New +$7.79K ﹤0.01% 4531
2023
Q1
Sell
-2,400
Closed -$139K 4883
2022
Q4
$139K Sell
2,400
-660
-22% -$40.8K ﹤0.01% 3812
2022
Q3
$288K Buy
3,060
+1,010
+49% +$144K ﹤0.01% 3395
2022
Q2
$457K Buy
2,050
+1,990
+3,317% +$666K ﹤0.01% 2983
2022
Q1
$33K Sell
60
-260
-81% -$157K ﹤0.01% 4627
2021
Q4
$211K Sell
320
-810
-72% -$619K ﹤0.01% 3813
2021
Q3
$949K Buy
1,130
+810
+253% +$822K ﹤0.01% 2259
2021
Q2
$406K Buy
+320
New +$361K ﹤0.01% 3141
2020
Q3
Sell
-950
Closed -$665K 4152
2020
Q2
$665K Buy
+950
New +$549K ﹤0.01% 2018

Other funds holding CDLX

Walleye Trading's CDLX Position: Q4 2025 in Review

Walleye Trading sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 136 shares — an estimated $3.29K sold.

Walleye Trading first reported a position in CDLX in Q4 2019 and held it in 11 quarters. The position peaked at $298K in Q2 2022. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Walleye Trading reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 136 Cardlytics shares in Q4 2025, an estimated $3.29K.
  • Walleye Trading first reported a position in Cardlytics in Q4 2019 and held it in 11 quarters.
  • Walleye Trading's Cardlytics position peaked at $298K in Q2 2022.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.